Author: Sihan Meng, Leyu Zhu, Pengcheng Shi
Affiliation: RSBM
Email: pengchengshi@biotechrs.com; pcspc9@gmail.com
Abstract
In product development for Oral Disintegrating Films (ODFs) and other advanced dosage forms, a recurring misconception is that a formulation “recipe” alone is sufficient to achieve commercialization. In reality, many projects fail not due to incorrect ingredients, but because formulation, process, equipment, packaging, and regulatory considerations are treated as disconnected tasks. This paper critically examines the difference between a simple recipe-based approach and a complete product solution. By comparing outcomes across development stages, we demonstrate why a systems-level, end-to-end solution is essential for scalable, compliant, and commercially successful products. The analysis provides practical guidance for brands deciding between purchasing formulas and investing in integrated product solutions.
Introduction
With increasing access to formulation knowledge, ingredient catalogs, and even AI-generated recipes, it has become easier than ever to obtain a “formula” for supplements, oral films, or functional products. However, ease of access has created an illusion: that a list of ingredients and ratios equates to a viable product [1].
In ODF manufacturing especially, products are not defined by formulation alone. They are defined by how the formulation behaves during coating, drying, cutting, packaging, storage, and consumer use [2]. This paper addresses a fundamental question faced by startups and established brands alike: Is a recipe enough, or is a complete product solution required?
Methods
We conducted a comparative analysis of two development pathways—recipe-based development and integrated product-solution development—using literature review, manufacturing theory, and industrial case experience. Each pathway was evaluated across formulation robustness, scale-up success, quality consistency, regulatory readiness, and commercial sustainability. Outcomes were analyzed qualitatively to highlight structural differences rather than individual formulation details [3].
Defining the Two Approaches
Recipe-Based Approach
A recipe-based approach typically includes:
Ingredient list and ratios
Basic preparation steps
Laboratory-scale feasibility
This approach treats formulation as an isolated task and assumes downstream processes can adapt accordingly.
Complete Product Solution
A complete product solution integrates:
Formulation design
Process and equipment matching
Packaging strategy
Quality and regulatory alignment
Scale-up and mass-production planning
Here, formulation is one component of a closed-loop system [4].
Limitations of the Recipe-Based Approach
Scale-Up Failure
Many formulations that work in beakers or small casting trays fail in continuous production due to viscosity drift, drying defects, or mechanical weakness [5].
Hidden Costs
A “cheap” recipe often leads to expensive trial-and-error cycles, wasted materials, and delayed launches when process incompatibilities emerge.
Regulatory Gaps
Recipes rarely address documentation, validation, or reproducibility—key requirements for regulated or semi-regulated markets [6].
Advantages of a Complete Product Solution
Process-Ready Formulation
Formulations are designed within known process windows (coating, drying, cutting), reducing scale-up risk from the outset [7].
Equipment Compatibility
Equipment selection and configuration are aligned with formulation behavior, not forced post hoc.
Packaging Integration
Packaging is treated as part of the dosage form, ensuring stability, compliance, and consumer usability [8].
Predictable Commercialization
Time-to-market becomes measurable and repeatable, rather than experimental.
Measures
The effectiveness of each approach can be evaluated using [9,10]:
First-batch success rate at scale
Number of reformulation cycles
Time-to-market
Yield loss and scrap rate
Regulatory readiness (documentation completeness)
These measures consistently favor integrated product solutions over recipe-only development.
Results
Across industrial experience and reported case studies, recipe-based projects show high early optimism but low scale-up success. In contrast, projects developed as complete product solutions demonstrate higher initial investment but significantly improved predictability, lower total cost, and faster commercialization [11].
Discussion
The popularity of recipe-based thinking reflects a misunderstanding of where value is created in modern manufacturing. In reality, value lies in reducing uncertainty. A complete product solution shifts effort from repeated troubleshooting to upfront system design.
For ODFs, where material science, process engineering, and packaging are tightly coupled, the recipe alone represents only a small fraction of the required knowledge. Brands that recognize this distinction gain a structural advantage in speed, quality, and long-term scalability [12].
Conclusion
A recipe list answers the question “What could work in theory?” A complete product solution answers “What will work reliably, at scale, and in the market?” For advanced dosage forms such as ODFs, sustainable success depends on integrated solutions that align formulation, process, equipment, packaging, and compliance from the beginning. Brands seeking predictable commercialization should prioritize complete product solutions over isolated recipes.
References
Fu Y et al. Expert Opin Drug Deliv. 2004;1(4):673–690.
Preis M. J Pharm Pharmacol. 2013;65(2):157–170.
Cilurzo F et al. Eur J Pharm Biopharm. 2008;70(3):895–900.
Dixit RP, Puthli SP. J Control Release. 2009;139(2):94–107.
Morales JO, McConville JT. Ther Deliv. 2011;2(5):637–646.
USP <905> Uniformity of Dosage Units.
Hoffmann EM et al. Pharm Res. 2011;28(8):1914–1922.
Borges AF et al. Int J Pharm. 2015;494(1):332–339.
Hopp WJ, Spearman ML. Factory Physics. McGraw-Hill; 2011.
USP <701> Disintegration Test.
Keshari R, Keshari S. J Drug Deliv Ther. 2014;4(4):1–7.
Preis M. Drug Dev Ind Pharm. 2013;39(7):1049–1057.